Company / Profit Margin
Amphstar Pharmaceuticals, Inc. Profit Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
13.6%
FY2025
5-year range
13.6% / 21.8%
FY2021-FY2025
Trend
-37.4%
vs FY2024
Sector context
#34 of 146
Health Care
What the data says
Amphstar Pharmaceuticals, Inc.'s profit margin of 13.6% is higher than 77% of companies in the Health Care sector (FY2025). Profit Margin has fluctuated over the past 10 years, ranging from -1.9% in FY2018 to 21.8% in FY2024.
Based on SEC 10-K filings.
13.6% in FY2025 with a 5-year CAGR of +13.2%. Top quartile in the Health Care sector.
Declined from 21.3% to 13.6% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- -4.7pp
- 5-Year Change
- +13.2pp
- 10-Year Change
- -
Sector benchmark
+101.7% above sector average
Key checks
Key Insights
- In FY2025, profit margin decreased 37.4% year-over-year.
- Currently 809.9pp above the Health Care sector average.
- Peak profit margin was recorded in FY2024.
- Lowest profit margin in the period was in FY2018.
Company context
Key Data Points
- Strong profit margin: 21.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 13.6% | -37.4% |
| FY2024 | 21.8% | +2.1% |
| FY2023 | 21.3% | +16.5% |
| FY2022 | 18.3% | +29.0% |
| FY2021 | 14.2% | +3447.5% |
| FY2020 | 0.4% | -97.4% |
| FY2019 | 15.2% | +878.5% |
| FY2018 | -1.9% | -228.3% |
| FY2017 | 1.5% | -60.5% |
| FY2016 | 3.9% | +446.8% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026